Dermata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerald T. Proehl
CEOGerald T. Proehl
Employees8
Employees8
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees8
Employees8
DRMA Key Statistics
Market cap4.48M
Market cap4.48M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume95.89K
Average volume95.89K
High today$0.7143
High today$0.7143
Low today$0.6899
Low today$0.6899
Open price$0.71
Open price$0.71
Volume50.05K
Volume50.05K
52 Week high$5.00
52 Week high$5.00
52 Week low$0.6611
52 Week low$0.6611
People also own
Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.